Skip to main content
Clinical Trials/PACTR201505001076143
PACTR201505001076143Other未知

IMPACT OF MORINGA OLEIFERA SUPPLEMENTATION ON BODY MASS INDEX AND IMMUNE RESPONSE OF HIV-PATIENTS UNDER ANTIRETROVIRAL THERAPY A SINGLE BLIND RANDOMIZED CLINICAL TRIA

Public Health School, Université Libre de Brussels0 sites0 target enrollmentStarted: March 17, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Other
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Year(s) to 60 Year(s) (—)
Sex
All

Inclusion Criteria

  • the patients included in the study had 18 years old above, treated with ART, at clinical stages 2 and 3 or 4 according to WHO classification but stabilied (without opportunisctic affection upon inclusion in the study). Without renal dysfunction, without adverse symptoms of malabsorption (digestive i.d without diarrhea in the three weeks preceding the beginning of study), and with a stable weight curve tree going months preceding the intervention study.

Exclusion Criteria

  • were excluded from study pregnant women patients and patient who were in stages 1,2 ,3 and 4 but not stabilized, as welle as those who did attend not consent, or who did not attend the consultation. In addition to those with renal dysfunction.

Investigators

Sponsor
Public Health School, Université Libre de Brussels

Similar Trials